Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

544 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The fungal gut microbiota in pediatric-onset multiple sclerosis.
Mok N, Knox NC, Zhu F, Arnold DL, Bar-Or A, Bernstein CN, Bonner C, Forbes JD, Graham M, Marrie RA, O'Mahony J, Yeh EA, Zhao Y, Van Domselaar G, Banwell B, Waubant E, Tremlett HL. Mok N, et al. Among authors: arnold dl. Front Microbiol. 2024 Dec 18;15:1258978. doi: 10.3389/fmicb.2024.1258978. eCollection 2024. Front Microbiol. 2024. PMID: 39744394 Free PMC article.
Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis.
Montalban X, Arnold DL, Weber MS, Staikov I, Piasecka-Stryczynska K, Willmer J, Martin EC, Dangond F, Syed S, Wolinsky JS; Evobrutinib Phase 2 Study Group. Montalban X, et al. Among authors: arnold dl. N Engl J Med. 2019 Jun 20;380(25):2406-2417. doi: 10.1056/NEJMoa1901981. Epub 2019 May 10. N Engl J Med. 2019. PMID: 31075187 Clinical Trial.
A data-driven model of disability progression in progressive multiple sclerosis.
Garbarino S, Tur C, Lorenzi M, Pardini M, Piana M, Uccelli A, Arnold DL, Cree BAC, Sormani MP, Bovis F. Garbarino S, et al. Among authors: arnold dl. Brain Commun. 2024 Dec 3;7(1):fcae434. doi: 10.1093/braincomms/fcae434. eCollection 2025. Brain Commun. 2024. PMID: 39777254 Free PMC article.
Lichen Planus.
Arnold DL, Krishnamurthy K. Arnold DL, et al. 2024 Oct 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Oct 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30252382 Free Books & Documents.
Choroid Plexus Volume in Pediatric-Onset Multiple Sclerosis.
Grasso EA, Bloy L, Kaplan P, Bar-Or A, Yeh EA, Arnold DL, Narayanan S, Marrie RA, Fadda G, Banwell BL; Canadian Demyelinating Disease Network. Grasso EA, et al. Among authors: arnold dl. Neurol Neuroimmunol Neuroinflamm. 2024 Nov;11(6):e200319. doi: 10.1212/NXI.0000000000200319. Epub 2024 Oct 23. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 39442038 Free PMC article.
Pharmacokinetics and Pharmacodynamics of Natalizumab 6-Week Dosing vs Continued 4-Week Dosing for Relapsing-Remitting Multiple Sclerosis.
Foley JF, Defer G, Ryerson LZ, Cohen JA, Arnold DL, Butzkueven H, Cutter GR, Giovannoni G, Killestein J, Wiendl H, Li K, Dsilva L, Toukam M, Ferber K, Sohn J, Engelman H, Lasky T. Foley JF, et al. Among authors: arnold dl. Neurol Neuroimmunol Neuroinflamm. 2024 Dec;11(6):e200321. doi: 10.1212/NXI.0000000000200321. Epub 2024 Oct 11. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 39393045 Free PMC article. Clinical Trial.
Prognostic factors for worsening and improvement in multiple sclerosis using a multistate model.
Ocampo A, Hatami F, Čuklina J, Graham G, Ganjgahi H, Sun Y, Su W, Mousseau MC, Gardiner S, Pendleton SC, Aarden P, Kieseier BC, Arnold DL, Bermel RA, Häring DA, Nichols TE, Wiendl H. Ocampo A, et al. Among authors: arnold dl. Mult Scler. 2024 Oct;30(11-12):1455-1467. doi: 10.1177/13524585241275471. Epub 2024 Sep 28. Mult Scler. 2024. PMID: 39340359
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.
Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BAC, Cross AH, Kubala Havrdova E, Kappos L, Stuve O, Wiendl H, Wolinsky JS, Dahlke F, Le Bolay C, Shen Loo L, Gopalakrishnan S, Hyvert Y, Javor A, Guehring H, Tenenbaum N, Tomic D; evolutionRMS investigators. Montalban X, et al. Among authors: arnold dl. Lancet Neurol. 2024 Nov;23(11):1119-1132. doi: 10.1016/S1474-4422(24)00328-4. Epub 2024 Sep 19. Lancet Neurol. 2024. PMID: 39307151 Clinical Trial.
544 results